Niagen Bioscience Inc ( NAGE) - Key Metrics
NAGE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.43 | $0.05 | $0.01 | $0.01 |
| 2025Q3 | $0.37 | $0.05 | $0.04 | $0.04 |
| 2025Q2 | $0.39 | $0.05 | $0.02 | $0.01 |
| 2025Q1 | $0.39 | $0.07 | $0.10 | $0.10 |
NAGE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 30.39 |
| 2025Q3 | ? | 46.65 |
| 2025Q2 | ? | 79.11 |
| 2025Q1 | ? | 26.51 |
NAGE
Price: $3.43
52 week price:
Earnings Per Share: 0.21 USD
P/E Ratio: 18.95
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 274.8 million